Announcements Trials
Browse Landscape

Status

Completed 180Recruiting 86Unknown 63Terminated 26Active not recruiting 23Not yet recruiting 18Withdrawn 11Enrolling by invitation 4

Sponsor Class

OTHER 3NIH 1

Study Type

Observational 4Interventional 4

Sponsor

Cancer Type

Gastrointestinal 80Breast 44Thoracic 30Other hematologic neoplasm 25Genitourinary 25Lymphoid 20Head & Neck 16CNS 16Tumor-Agnostic 13Dermatologic 13Endocrine 12Other solid neoplasm 11Gynecologic 11Classical hematology 7Plasma cell 6Myeloid 4Sarcoma 3Other 3NET 3

Conditions

Myelodysplastic Syndromes 2Leukemia, Myelogenous, Chronic, BCR-ABL Positive 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Myeloproliferative Disorders 1Lymphoproliferative Disorders 1Lymphoma, Non-Hodgkin 1Leukemia, Myeloid, Acute 1Hodgkin Disease 1

Interventions

olverembatinib 1Imatinib Mesylate 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Enrolling by invitation × Observational × Myeloid × Clear all
NCT00923442 2026-04-27

Biology Studies of Hematologic Cancers

National Institutes of Health Clinical Center (CC)

Enrolling by invitation
550 enrolled
LymphoidMyeloidOther hematologic neoplasm

Hodgkin Disease, Lymphoma, Non-Hodgkin, Myelodysplastic Syndromes, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT01728402 2026-02-17

Pathogenesis of Hematologic Malignancies

OHSU Knight Cancer Institute

Enrolling by invitation
5,000 enrolled
LymphoidMyeloid

Lymphoproliferative Disorders, Myelodysplastic Syndromes, Myeloproliferative Disorders

NCT07383298 2026-02-03

Observational Study on Dose Optimization of Olverembatinib in Patients With Chronic Myeloid Leukemia in Chronic or Accelerated Phase

Peking University People's Hospital

Enrolling by invitation
100 enrolled
MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT06646978 2024-10-17

K2SPIRIT

Poitiers University Hospital

Enrolling by invitation
787 enrolled
MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡